2024

Heart Failure Esc 2024

Heart Failure Esc 2024. Yang (united kingdom of great britain & northern ireland,gb). Retatrutide improves lipid and cardiovascular risk profile in phase ii trial.


Heart Failure Esc 2024

Optimally treated patients without heart failure in the reperfusion era: Yang (united kingdom of great britain & northern ireland,gb).

Heart Failure Esc 2024 Images References :